Parkinson's disease is a debilitating neuropathology associated with the loss of nigrostriatal dopaminergic neurons. Interestingly, cardinal symptoms of resting tremor, rigidity and akinesia do not occur until denervation is extensive. Animal studies indicate that motor function is normalized by the maintenance of dopaminergic tone, the ambient concentration of dopamine in brain extracellular fluid. How dopaminergic tone is maintained despite the near complete loss of dopaminergic neurons has been the focus of previous work by PI Garris. In this project, efforts will be directed at examining, in the severely dopamine-depleted striatum, why dopaminergic signaling fails and how L-DOPA acts. L-DOPA is the primary medication used to treat Parkinson's disease today. Voltammetric microsensor experiments will be performed in an animal model, the 6-hydroxydopamine-lesioned rat. These probes, monitoring dopamine with millisecond temporal and micron spatial resolution, permit direct assessment of the central mechanisms of extracellular dopaminergic neurotransmission, release, uptake and diffusion.
Specific Aim 1 characterizes compensatory adaptation of DA release and uptake, and the relationship between DA diffusion, synthesis and metabolism. The goal is a more comprehensive view of dopaminergic signaling.
Specific Aim 2 characterizes the effects of L-DOPA on DA release, uptake and diffusion, and on tonic and phasic dopaminergic signaling. Whereas tonic signaling generates dopaminergic tone, phasic signaling produces a transient concentration spike on top of ambient dopamine levels. Phasic signaling is activated by salient stimuli and thought to be important for associative learning. The proposed research is significant, because how and why dopaminergic signaling fails in the severely lesioned striatum is poorly understood. Moreover, L-DOPA is associated with adverse side effects after extended use, apparently due to non-physiological dopamine replacement. However, how L-DOPA acts on dopaminergic signaling is not completely established.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
2R15NS035298-03
Application #
6954466
Study Section
Clinical Neuroplasticity and Neurotransmitters Study Section (CNNT)
Program Officer
Oliver, Eugene J
Project Start
1997-05-15
Project End
2009-07-31
Budget Start
2005-08-01
Budget End
2009-07-31
Support Year
3
Fiscal Year
2005
Total Cost
$210,000
Indirect Cost
Name
Illinois State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
001898142
City
Normal
State
IL
Country
United States
Zip Code
61790
Bergstrom, B P; Sanberg, S G; Andersson, M et al. (2011) Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism. Neuroscience 193:310-22
Bergstrom, Brian P; Garris, Paul A (2003) ""Passive stabilization"" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 87:1224-36
Venton, B Jill; Zhang, Hui; Garris, Paul A et al. (2003) Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem 87:1284-95
Garris, Paul A; Rebec, George V (2002) Modeling fast dopamine neurotransmission in the nucleus accumbens during behavior. Behav Brain Res 137:47-63
Wu, Qun; Reith, Maarten E A; Walker, Q David et al. (2002) Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci 22:6272-81
Wu, Q; Reith, M E; Wightman, R M et al. (2001) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods 112:119-33
Wu, Q; Reith, M E; Kuhar, M J et al. (2001) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci 21:6338-47
Bergstrom, B P; Schertz, K E; Weirick, T et al. (2001) Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism. J Neurosci Methods 106:15-28
Bergstrom, B P; Garris, P A (1999) Utility of a tripolar stimulating electrode for eliciting dopamine release in the rat striatum. J Neurosci Methods 87:201-8